Chinese bulk aspirin
This article was originally published in The Tan Sheet
Executive Summary
Jilin Henghe Pharmaceutical and Shandong Xinhua Pharmaceutical did not sell bulk aspirin in the U.S. "below normal value" from July 1, 2001 through June 30, 2002, International Trade Administration says Aug. 13. ITA determines no antidumping duties should be imposed on the two Chinese companies; antidumping margin of 144% applicable to other bulk aspirin exporters based in the People's Republic of China remains unchanged. In July 2000, U.S. Customs service imposed antidumping duties of 16.5% on Shandong, 10.9% on Jilin (1"The Tan Sheet" July 3, 2000, p. 2)...